Pnc Financial Services Group, Inc. Bei Gene, Ltd. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 778 shares of BGNE stock, worth $167,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares

778

Previous 879 11.49%

Holding current value

$167,270

Previous $125,000 39.2%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$143.93 - $224.51 $14,536 - $22,675	-101 Reduced 11.49%	778 $174,000
Q2 2024 Aug 09, 2024	BUY	$129.52 - $174.32 $32,898 - $44,277	254 Added 40.64%	879 $125,000
Q1 2024 May 10, 2024	BUY	$141.8 - $181.47 $30,345 - $38,834	214 Added 52.07%	625 $97,000
Q4 2023 Feb 09, 2024	SELL	$158.67 - $201.58 $50,933 - $64,707	-321 Reduced 43.85%	411 $74,000
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $72,847 - $91,177	405 Added 123.85%	732 $131,000
Q2 2023 Aug 11, 2023	BUY	$178.3 - $266.78 $7,845 - $11,738	44 Added 15.55%	327 $58,000
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $8,405 - $10,705	39 Added 15.98%	283 $60,000
Q4 2022 Feb 10, 2023	BUY	$125.51 - $229.3 $6,401 - $11,694	51 Added 26.42%	244 $53,000
Q3 2022 Nov 10, 2022	BUY	$131.8 - $202.24 $9,094 - $13,954	69 Added 55.65%	193 $26,000
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $24,464 - $43,642	-202 Reduced 61.96%	124 $20,000
Q1 2022 May 12, 2022	SELL	$146.52 - $269.56 $10,842 - $19,947	-74 Reduced 18.5%	326 $61,000
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $38,029 - $59,569	-153 Reduced 27.67%	400 $108,000
Q3 2021 Nov 05, 2021	BUY	$249.6 - $403.14 $11,731 - $18,947	47 Added 9.29%	553 $200,000
Q2 2021 Aug 06, 2021	SELL	$292.75 - $367.01 $9,660 - $12,111	-33 Reduced 6.12%	506 $173,000
Q1 2021 May 07, 2021	BUY	$260.64 - $382.12 $14,074 - $20,634	54 Added 11.13%	539 $187,000
Q4 2020 Feb 12, 2021	BUY	$221.31 - $316.61 $5,090 - $7,282	23 Added 4.98%	485 $125,000
Q3 2020 Nov 06, 2020	BUY	$189.18 - $286.44 $3,405 - $5,155	18 Added 4.05%	462 $132,000
Q2 2020 Aug 07, 2020	BUY	$123.9 - $195.41 $11,274 - $17,782	91 Added 25.78%	444 $83,000
Q1 2020 May 08, 2020	SELL	$121.84 - $173.19 $609 - $865	-5 Reduced 1.4%	353 $43,000
Q3 2019 Nov 08, 2019	SELL	$120.61 - $148.29 $9,286 - $11,418	-77 Reduced 17.7%	358 $43,000
Q2 2019 Aug 09, 2019	BUY	$113.99 - $146.86 $45,937 - $59,184	403 Added 1259.38%	435 $0
Q1 2019 May 10, 2019	SELL	$122.82 - $151.83 $37,337 - $46,156	-304 Reduced 90.48%	32 $0
Q4 2018 Feb 08, 2019	BUY	$107.01 - $175.15 $35,955 - $58,850	336 New	336 $47,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Bei Gene, Ltd. Transaction History